サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1794562

眼筋麻痺の世界市場

Ophthalmoplegia

出版日
ページ情報
英文 276 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.55円
眼筋麻痺の世界市場
出版日: 2025年08月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 276 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

眼筋麻痺の世界市場は2030年までに18億米ドルに達する

2024年に13億米ドルと推定される眼筋麻痺の世界市場は、2024年から2030年にかけてCAGR 4.8%で成長し、2030年には18億米ドルに達すると予測されます。眼筋麻痺レポートで分析したセグメントの1つである医薬品は、CAGR 5.7％を記録し、分析期間終了までに11億米ドルに達すると予測されます。眼筋麻痺医療機器セグメントの成長率は、分析期間中CAGR 3.1%と推定されます。

米国市場は3億6,130万米ドルと推定、中国はCAGR 8.8％で成長予測

米国の眼筋麻痺市場は、2024年に3億6,130万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.8%で推移し、2030年には3億7,010万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.9%と3.8%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の眼筋麻痺治療情勢-主要動向と促進要因のまとめ

眼筋麻痺の診断と管理に対する臨床上の注目の原動力は何か？

眼筋麻痺とは、眼筋の麻痺または脱力を指し、正常な眼球運動を制限し、1つまたは複数の眼外筋に影響を及ぼす可能性があります。この疾患は、脳神経麻痺、脳卒中、外傷、多発性硬化症、感染症、または慢性進行性外反症などのまれなミトコンドリア病など、さまざまな根本的原因によって起こる可能性があります。患者は、複視、眼瞼下垂、視線制御障害、バランス障害や協調運動障害を経験することがあります。

神経症状に対する認識が高まり、神経眼科診断へのアクセスが改善されたことで、早期発見と介入が可能となっています。MRIやCTスキャンなどの画像診断技術は眼球運動評価や血液検査と組み合わされ、原因疾患の特定や先天性、後天性、進行性の鑑別に使用されています。脳卒中、糖尿病関連ニューロパチー、自己免疫疾患の増加により、二次的な眼筋麻痺を呈する患者数が増加しており、その管理により臨床的焦点が当てられています。

現在の治療法は根本的な原因や疾患の進行とどのように整合しているのか？

眼筋麻痺の治療は、根本的な原因や筋病変の重症度に大きく左右されるため、万能なアプローチは存在しないです。感染、炎症、自己免疫反応に関連している場合は、症状を抑えるためにコルチコステロイドや免疫抑制剤が処方されます。糖尿病や血管障害による脳神経麻痺の場合は、プリズム眼鏡や眼帯を使用して複視を管理しながら、原疾患に対処することが多いです。

複視が持続したり、眼球のアライメントに大きな影響がある場合には、斜視矯正などの外科的な選択肢が検討されます。ミトコンドリア性または進行性の神経変性に起因する患者は、理学療法や弱視リハビリテーションなどの支持療法を受けることがあります。場合によっては、既存の障害を回復させるのではなく、疾患の進行を止めることを目的とした治療が行われます。遺伝子検査や神経学的評価がより利用しやすくなるにつれて、正確な診断が、よりオーダーメイドで集学的な治療戦略を支えるようになってきています。

眼筋麻痺の広範なケア環境において、どのような動向が生まれているか？

眼筋麻痺のケアにおいて、多職種連携が果たす役割は大きくなっています。神経科医、眼科医、リハビリテーション専門医は、特に眼球運動障害に全身症状や認知症状が伴う場合、複雑な病態を管理するために協力することが多いです。患者のモニタリングは、特に慢性型や進行型の場合、生活の質と機能的自立の維持に重点を置いた長期的なケアの枠組みに移行しつつあります。

ウェアラブル・アイトラッキング技術と視覚トレーニング・アプリケーションの統合は、症状モニタリングとリハビリテーションに新たな道を提供しています。神経眼科学の進歩は、脳と眼筋の相互作用の理解を深め、診断プロトコルの改善につながります。さらに、希少なミトコンドリアおよび神経筋疾患に関する世界の認識向上努力は、特に若年層における臨床経路の早期特定に役立っています。

眼筋麻痺ケア・治療市場の成長を促進する要因とは？

眼筋麻痺ケア市場の成長は、いくつかの要因によってもたらされます。神経疾患、糖尿病に関連する神経損傷、自己免疫疾患の有病率の増加により、評価や介入を必要とする患者層が拡大しています。画像診断や診断能力の進歩により、筋肉や神経の病変をより早期に、より正確に特定することが可能になっています。神経筋疾患やミトコンドリア疾患に対する標的治療の開発により、稀な症例や進行性の症例における治療の選択肢が広がっています。専門的な神経眼科サービスの拡大により、集学的治療へのアクセスが向上しています。全身疾患と関連した眼症状に対する意識の高まりは、タイムリーな紹介を促し、診断の遅れを減少させています。これらの要因を総合すると、世界のヘルスケアシステム全体において、眼筋麻痺のより体系的で効果的な管理経路が支援されています。

セグメント

製品タイプ（眼筋麻痺医薬品、眼筋麻痺医療機器）;最終用途（病院、診療所、外来診療所）

調査対象企業の例

  • Accutome（Keeler）
  • AcuSurgical
  • Allergan（AbbVie）
  • Appasamy Associates
  • Barraquer Institute（neuromodulators）
  • Daewoong Pharmaceutical（Nabota/Jeuveau）
  • Duckworth & Kent
  • Eyenovia Inc.（topical/neuro）
  • Evolus（Jeuveau）
  • Ipsen（Dysport）
  • Keeler（Accutome）
  • Medytox（Neuronox）
  • Optonol / Belkin Vision
  • Preceyes BV
  • Rayner
  • Schwind eye-tech-solutions
  • Storz (Bausch + Lomb)
  • Teva Pharmaceutical（Xeomin）
  • VisuMax/Carl Zeiss（MIGS devices）
  • Ziemer Ophthalmic Systems

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中のドメイン専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37589

Global Ophthalmoplegia Market to Reach US$1.8 Billion by 2030

The global market for Ophthalmoplegia estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Ophthalmoplegia Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Ophthalmoplegia Medical Devices segment is estimated at 3.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$361.3 Million While China is Forecast to Grow at 8.8% CAGR

The Ophthalmoplegia market in the U.S. is estimated at US$361.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$370.1 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Ophthalmoplegia Treatment Landscape - Key Trends & Drivers Summarized

What Is Driving Clinical Attention Toward Ophthalmoplegia Diagnosis and Management?

Ophthalmoplegia refers to the paralysis or weakness of the eye muscles, which restricts normal eye movement and may affect one or more of the extraocular muscles. This condition can result from various underlying causes including cranial nerve palsies, stroke, trauma, multiple sclerosis, infections, or rare mitochondrial diseases such as chronic progressive external ophthalmoplegia. Patients may experience double vision, drooping eyelids, impaired gaze control, and difficulties with balance or coordination.

Growing awareness of neurological symptoms and improved access to neuro-ophthalmology diagnostics are enabling earlier recognition and intervention. Imaging techniques such as MRI and CT scans, combined with ocular motility assessments and blood tests, are being used to identify causative conditions and differentiate between congenital, acquired, or progressive forms of the disorder. Rising incidence of stroke, diabetes-related neuropathy, and autoimmune disorders is increasing the number of patients presenting with secondary ophthalmoplegia, prompting greater clinical focus on its management.

How Are Current Therapies Aligned with Underlying Causes and Disease Progression?

There is no one-size-fits-all approach to treating ophthalmoplegia, as therapeutic strategies depend heavily on the underlying cause and severity of muscle involvement. In cases where the condition is linked to infection, inflammation, or autoimmune reactions, corticosteroids or immunosuppressants are typically prescribed to control symptoms. For cases involving cranial nerve palsy from diabetes or vascular events, management often includes addressing the primary disease while using prism glasses or eye patches to manage double vision.

Surgical options such as strabismus correction are considered in cases where diplopia persists or ocular alignment is significantly affected. Patients with mitochondrial or progressive neurodegenerative origins may receive supportive care, including physical therapy and low vision rehabilitation. In some instances, treatments are aimed at halting disease progression rather than reversing existing damage. As genetic testing and neurological evaluation become more accessible, accurate diagnosis is supporting more tailored and multidisciplinary treatment strategies.

What Trends Are Emerging in the Broader Care Environment for Ophthalmoplegia?

Multidisciplinary collaboration is playing a growing role in ophthalmoplegia care. Neurologists, ophthalmologists, and rehabilitation specialists often work together to manage complex presentations, especially when ocular motor deficits are accompanied by systemic or cognitive symptoms. Patient monitoring is shifting toward long-term care frameworks, particularly in chronic or progressive forms, with a focus on maintaining quality of life and functional independence.

The integration of wearable eye-tracking technologies and visual training applications is providing new avenues for symptom monitoring and rehabilitation. Advances in neuro-ophthalmology are supporting better understanding of brain-eye muscle interactions, leading to improved diagnostic protocols. Additionally, global awareness efforts around rare mitochondrial and neuromuscular disorders are helping identify ophthalmoplegia earlier in clinical pathways, especially among younger populations.

What Factors Are Driving Growth in the Ophthalmoplegia Care and Therapeutics Market?

Growth in the ophthalmoplegia care market is driven by several factors. Increasing prevalence of neurological conditions, diabetes-related nerve damage, and autoimmune disorders is expanding the patient population requiring evaluation and intervention. Advancements in imaging and diagnostic capabilities are enabling earlier and more accurate identification of muscle and nerve involvement. Development of targeted therapies for neuromuscular and mitochondrial diseases is broadening treatment options in rare and progressive cases. Expansion of specialized neuro-ophthalmology services is improving multidisciplinary access to care. Rising awareness of ocular symptoms linked to systemic disease is encouraging timely referrals and reducing diagnostic delays. Collectively, these factors are supporting more structured and effective management pathways for ophthalmoplegia across global healthcare systems.

SCOPE OF STUDY:

The report analyzes the Ophthalmoplegia market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Ophthalmoplegia Pharmaceuticals, Ophthalmoplegia Medical Devices); End-Use (Hospitals End-Use, Clinics End-Use, Ambulatory Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Accutome (Keeler)
  • AcuSurgical
  • Allergan (AbbVie)
  • Appasamy Associates
  • Barraquer Institute (neuromodulators)
  • Daewoong Pharmaceutical (Nabota/Jeuveau)
  • Duckworth & Kent
  • Eyenovia Inc. (topical/neuro)
  • Evolus (Jeuveau)
  • Ipsen (Dysport)
  • Keeler (Accutome)
  • Medytox (Neuronox)
  • Optonol / Belkin Vision
  • Preceyes BV
  • Rayner
  • Schwind eye-tech-solutions
  • Storz (Bausch + Lomb)
  • Teva Pharmaceutical (Xeomin)
  • VisuMax/Carl Zeiss (MIGS devices)
  • Ziemer Ophthalmic Systems

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Ophthalmoplegia - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neuro-Ophthalmic Disorders and Stroke-Related Complications Drives Demand for Ophthalmoplegia Diagnosis and Treatment
    • Increased Prevalence of Diabetes and Hypertension Expands Addressable Market for Secondary Ophthalmoplegia Management
    • Advancements in Neuroimaging and MRI Technologies Strengthen Early Detection and Differential Diagnosis Capabilities
    • Growth in Awareness and Screening for Rare Muscular and Nerve Disorders Spurs Identification of Congenital Ophthalmoplegia Cases
    • Development of Targeted Therapies and Supportive Treatments Enhances Clinical Outcomes for Cranial Nerve Palsy
    • Integration of Multidisciplinary Care Approaches, Including Neurology and Ophthalmology, Improves Patient Management Strategies
    • Adoption of Botulinum Toxin Therapy and Eye Muscle Surgery Supports Functional Rehabilitation in Select Cases
    • Increased Research on Mitochondrial Disorders and Genetic Mutations Fuels Innovation in Personalized Treatment Options
    • Technological Advancements in Assistive Vision Devices Promote Quality of Life for Patients with Partial or Chronic Paralysis
    • Rising Use of Steroids and Immunomodulators in Autoimmune-Linked Ophthalmoplegia Expands Treatment Applications
    • Growth in Pediatric Neurology Services Supports Early Intervention in Developmental Ocular Motor Disorders
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Ophthalmoplegia Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Ophthalmoplegia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ophthalmoplegia Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ophthalmoplegia Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Ophthalmoplegia Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ophthalmoplegia Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Ophthalmoplegia Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Ophthalmoplegia Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Ambulatory Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Ophthalmoplegia by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Ophthalmoplegia by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Ophthalmoplegia by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Ophthalmoplegia by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Ophthalmoplegia by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Ophthalmoplegia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Ophthalmoplegia by Product Type - Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Ophthalmoplegia by Product Type - Percentage Breakdown of Value Sales for Ophthalmoplegia Pharmaceuticals and Ophthalmoplegia Medical Devices for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Ophthalmoplegia by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Ophthalmoplegia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION